首页> Acta endocrinologica (Bucharest, Romania : 2005)> BODY MASS INDEX AS A PROGNOSTIC FACTOR FOR DISEASE PROGRESSION IN PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH BEVACIZUMAB BASED SYSTEMIC THERAPY.

BODY MASS INDEX AS A PROGNOSTIC FACTOR FOR DISEASE PROGRESSION IN PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH BEVACIZUMAB BASED SYSTEMIC THERAPY.

导出 LinkOut

翻译打印收藏纠错

第一作者： C,Hopirtean

第一单位： "Ion Chiricuţă" Oncology Institute, Cluj-Napoca, Romania.

作者： C,Hopirtean ^[1] ; T,Ciuleanu ^[2] ; C,Cainap ^[2] ; N,Todor ^[1] ; V,Nagy ^[2]

作者单位： "Ion Chiricuţă" Oncology Institute, Cluj-Napoca, Romania. ^[1] "Ion Chiricuţă" Oncology Institute, Cluj-Napoca, Romania.;"Iuliu Haţieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. ^[2]

关键词 bevacizumab body mass index metastatic colorectal cancer overall survival progression free survival

DOI 10.4183/aeb.2017.425

PMID 31149211

发布时间 2024-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Acta endocrinologica (Bucharest, Romania

425-430页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Acta endocrinologica (Bucharest, Romania

425-430页

检索历史清除

BODY MASS INDEX AS A PROGNOSTIC FACTOR FOR DISEASE PROGRESSION IN PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH BEVACIZUMAB BASED SYSTEMIC THERAPY.

Acta endocrinologica (Bucharest, Romania

相似文献

同项目论文

Acta endocrinologica (Bucharest, Romania

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

BODY MASS INDEX AS A PROGNOSTIC FACTOR FOR DISEASE PROGRESSION IN PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH BEVACIZUMAB BASED SYSTEMIC THERAPY.

Acta endocrinologica (Bucharest, Romania

相似文献

同项目论文

Acta endocrinologica (Bucharest, Romania

相关期刊

检索历史清除